Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Quik

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Neuroscience|June 16, 2000
Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatmentM Quik, S Police, L He, et al.
Molecular Pharmacology|January 1, 1990
Thymopoietin, a thymic polypeptide, regulates nicotinic alpha-bungarotoxin sites in chromaffin cells in cultureM Quik, R Afar, S Geertsen, et al.
Neuroscience|April 2, 2005
Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeysL Chen, D M Togasaki, J W Langston, et al.
The Journal of Comparative Neurology|August 15, 2000
Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridizationM Quik, Y Polonskaya, A Gillespie, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Further evidence for the existence of multiple receptors for dopamine in the central nervous systemL L Iversen, M Quik, P C Emson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate modelD A Di Monte, A McCormack, G Petzinger, et al.
Annals of Neurology|August 17, 2001
Levodopa induces dyskinesias in normal squirrel monkeysD M Togasaki, L Tan, P Protell, et al.
Molecular Pharmacology|September 1, 1993
Notice of retractionM Quik, R Afar, S Geertsen, et al.
Life Sciences|August 7, 1978
3H-Spiperone binding in normal and schizophrenic post-mortem human brainA V Mackay, A Doble, E D Bird, et al.
British Journal of Pharmacology|February 1, 1994
The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglionP B Clarke, I Chaudieu, H el-Bizri, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Neuroscience|June 16, 2000
Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatmentM Quik, S Police, L He, et al.
Molecular Pharmacology|January 1, 1990
Thymopoietin, a thymic polypeptide, regulates nicotinic alpha-bungarotoxin sites in chromaffin cells in cultureM Quik, R Afar, S Geertsen, et al.
Neuroscience|April 2, 2005
Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeysL Chen, D M Togasaki, J W Langston, et al.
The Journal of Comparative Neurology|August 15, 2000
Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridizationM Quik, Y Polonskaya, A Gillespie, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Further evidence for the existence of multiple receptors for dopamine in the central nervous systemL L Iversen, M Quik, P C Emson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate modelD A Di Monte, A McCormack, G Petzinger, et al.
Annals of Neurology|August 17, 2001
Levodopa induces dyskinesias in normal squirrel monkeysD M Togasaki, L Tan, P Protell, et al.
Molecular Pharmacology|September 1, 1993
Notice of retractionM Quik, R Afar, S Geertsen, et al.
Life Sciences|August 7, 1978
3H-Spiperone binding in normal and schizophrenic post-mortem human brainA V Mackay, A Doble, E D Bird, et al.
British Journal of Pharmacology|February 1, 1994
The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglionP B Clarke, I Chaudieu, H el-Bizri, et al.
Pageof 10